1.
D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental
glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43(2):368-82.
2.
Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic
adults: presentation, prognosis, and response to therapy of the histologic variants.
J Am Soc Nephrol. 2004;15(8):2169-77.
3.
Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, et al. Expression of
podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol.
2003;14(8):2063-71.
4.
Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int Suppl. 1996;57:S119-31.
5.
Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, et al. Clinical
trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int.
2011;80(8):868-78.
6.
Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 2002;62(6):2301-10.
7.
Deegens JK, Assmann KJ, Steenbergen EJ, Hilbrands LB, Gerlag PG, Jansen JL, et al.
Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated
patients? Neth J Med. 2005;63(10):393-8.
8.
Bagherzadegan H, Ossareh S, Asgari M. Clinocopathologic Correlation of renal biopsy
findings- An update report from a trtiary center. Abstracts of European Dialysis &
Transplant Association (ERA-EDTA) 55th. May 24-27, 2018, Copenhagen, Denmark
9.
D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int. 1994;46(4):1223-41.
10.
Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts
from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010;55(1
Suppl 1):S1-420, A6-7.
11.
D'Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, et al. Association
of histologic variants in FSGS clinical trial with presenting features and outcomes.
Clin J Am Soc Nephrol. 2013;8(3):399-406.
12.
Stokes MB, Valeri AM, Markowitz GS, D'Agati VD. Cellular focal segmental glomerulosclerosis:
Clinical and pathologic features. Kidney Int. 2006;70(10):1783-92.
13.
Chen YM, Liapis H. Focal segmental glomerulosclerosis: molecular genetics and targeted
therapies. BMC Nephrol. 2015;16:101.
14.
Gbadegesin R, Lavin P, Foreman J, Winn M. Pathogenesis and therapy of focal segmental
glomerulosclerosis: an update. Pediatr Nephrol. 2011;26(7):1001-15.
15.
Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol. 1998;9(7):1333-40.
16.
Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental
glomerulosclerosis in the United States. Am J Kidney Dis. 2004;44(5):815-25.
17.
Schwartz MM, Korbet SM. Primary focal segmental glomerulosclerosis: pathology, histological
variants, and pathogenesis. Am J Kidney Dis. 1993;22(6):874-83.
18.
Swarnalatha G, Ram R, Ismal KM, Vali S, Sahay M, Dakshinamurty KV. Focal and segmental
glomerulosclerosis: does prognosis vary with the variants? Saudi J Kidney Dis Transpl.
2015;26(1):173-81.
19.
Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, et al. Clinical outcomes and predictors
for ESRD and mortality in primary GN. Clin J Am Soc Nephrol. 2012;7(9):1401-8.
20.
Schwartz MM, Evans J, Bain R, Korbet SM. Focal segmental glomerulosclerosis: prognostic
implications of the cellular lesion. J Am Soc Nephrol. 1999;10(9):1900-7.
21.
Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, et al. Clinical
and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.
Kidney Int. 2006;69(5):920-6.
22.
Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D. Evolution of nephrotic-associated
focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney
Int. 2005;67(3):987-1001.
23.
Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, et al. Renal Survival
in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Clin J Am
Soc Nephrol. 2016;11(10):1752-9.
24.
Huppes W, Hene RJ, Kooiker CJ. The glomerular tip lesion: a distinct entity or not?
J Pathol. 1988;154(2):187-90.
25.
Kwon YE, Han SH, Kie JH, An SY, Kim YL, Park KS, et al. Clinical features and outcomes
of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.
BMC Nephrol. 2014;15:52.
26.
Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF. Pathological variants of focal segmental
glomerulosclerosis in an adult Dutch population--epidemiology and outcome. Nephrol
Dial Transplant. 2008;23(1):186-92.
27.
Taneda S, Honda K, Uchida K, Nitta K, Yumura W, Oda H, et al. Histological heterogeneity
of glomerular segmental lesions in focal segmental glomerulosclerosis. Int Urol Nephrol.
2012;44(1):183-96.
28.
Meehan SM, Chang A, Gibson IW, Kim L, Kambham N, Laszik Z. A study of interobserver
reproducibility of morphologic lesions of focal segmental glomerulosclerosis. Virchows
Arch. 2013;462(2):229-37.
29.
Han MH, Kim YJ. Practical Application of Columbia Classification for Focal Segmental
Glomerulosclerosis. Biomed Res Int. 2016;2016:9375753.
30.
Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation
of the renal biopsy. Am J Nephrol. 1988;8(2):85-9.
31.
Schachter AD. Computational simulation of renal biopsy accuracy in focal segmental
glomerulosclerosis. Pediatr Nephrol. 2006;21(7):953-7.
32.
Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, et al. International
standardization of criteria for the histologic diagnosis of renal allograft rejection:
the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44(2):411-22.
33.
Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med.
1998;339(20):1448-56.
34.
Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165-80.
35.
Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol.
2010;21(11):1819-34.
36.
Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao JC. Pathogenesis of chronic
renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial
nephritides. Kidney Int Suppl. 1996;54:S2-9.
37.
Elsherbiny HE, Alexander MP, Kremers WK, Park WD, Poggio ED, Prieto M, et al. Nephron
hypertrophy and glomerulosclerosis and their association with kidney function and
risk factors among living kidney donors. Clin J Am Soc Nephrol. 2014;9(11):1892-902.
38.
Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, et al. The association
between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med.
2010;152(9):561-7.
39.
Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL. Predicting renal survival in
primary focal glomerulosclerosis from the time of presentation. Kidney Int. 1999;56(6):2236-42.
40.
Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG. The long-term prognosis of
patients with focal segmental glomerulosclerosis. Clin Nephrol. 1978;10(6):213-8.
41.
Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, et al. An Outcomes-Based
Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis. Clin J
Am Soc Nephrol. 2018;13(3):414-21.